BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6643435)

  • 1. Increase of serotonin receptors in rat uterus induced by estradiol.
    Ichida S; Tokunaga H; Oda Y; Fujita N; Hirata A; Hata T
    J Biol Chem; 1983 Nov; 258(22):13438-43. PubMed ID: 6643435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol-induced increase of specific [3H]ketanserin binding sites on rat uterine membranes.
    Ichida S; Hayashi T; Kita T; Murakami T
    Eur J Pharmacol; 1985 Feb; 108(3):257-64. PubMed ID: 3157585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of specific change by estradiol in sensitivity of rat uterus to serotonin.
    Ichida S; Oda Y; Tokunaga H; Hayashi T; Murakami T; Kita T
    J Pharmacol Exp Ther; 1984 Apr; 229(1):244-9. PubMed ID: 6538599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
    Pilotte NS; Burt DR; Barraclough CA
    Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]-Spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery.
    Brodde OE; Gross G
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):249-54. PubMed ID: 7393340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The [3H]5-HT and [3H]spiroperidol binding sites in the rat frontal cortex and thermally inactivated at different rates.
    Poller D; Carroll JA; Middlemiss DN
    Eur J Pharmacol; 1981 Jun; 72(1):121-3. PubMed ID: 7262190
    [No Abstract]   [Full Text] [Related]  

  • 13. [3H]Spiroperidol binding in rat striatum: two high-affinity sites of differing selectivities.
    Andorn AC; Maguire ME
    J Neurochem; 1980 Nov; 35(5):1105-13. PubMed ID: 6256500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3H-Spiroperidol binding to striatal membranes of mutant Han-Wistar rats which exhibit spastic paresis.
    Golombiowska-Nikitin K; Sontag KH; Osborne NN
    Experientia; 1981 May; 37(5):490-1. PubMed ID: 7250319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain.
    Di Paolo T; Carmichael R; Labrie F; Raynaud JP
    Mol Cell Endocrinol; 1979 Nov; 16(2):99-112. PubMed ID: 116893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
    Pedigo NW; Yamamura HI; Nelson DL
    J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3H-spiroperidol binding sites in blood platelets.
    Khanna AS; Agrawal AK; Seth PK
    Biochem Biophys Res Commun; 1987 Aug; 146(3):983-8. PubMed ID: 3619946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.